Anticoagulant proves ‘promising’ in reducing dementia risk
Australian study shows AF patients on NOACs are less likely to experience cognitive decline than those on warfarin
![](https://www.ausdoc.com.au/wp-content/uploads/2022/08/Pills_NOAC_Pradaxa_Dabigatran_DT-5.jpg)
Patients with AF who take non-vitamin K antagonist oral anticoagulants instead of warfarin have half the risk of developing dementia, Australian findings show.
According to Tasmanian researchers, those prescribed non-vitamin K antagonist oral anticoagulants (NOACs) have a lower incidence of cognitive decline compared with adults on either warfarin or no anticoagulant.